Medicine for treating erythronoclastic anemia

A technology for hemolytic anemia and therapeutic drug is applied in the field of therapeutic drug for hemolytic anemia to achieve obvious and stable effect.

Inactive Publication Date: 2016-04-06
黄全
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

2. Hemolytic anemia caused by ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] A medicine for treating hemolytic anemia in an amount suitable for a patient with hemolytic anemia is further described as a preferred embodiment.

[0011] A dose of medicine for treating hemolytic anemia is composed of the following Chinese medicines: 15 grams of mulberries, 15 grams of leeches, 15 grams of Rehmannia glutinosa, 10 grams of seaweed, 15 grams of Tianjihuang, 15 grams of codonopsis, and 10 grams of red dates , Achyranthes bidentata 18 grams, turtle shell 15 grams, astragalus 15 grams, yam 20 grams, licorice 7 grams. A method of using a medicine for treating hemolytic anemia: taking decoction orally, taking one dose a day, taking 15 consecutive days as a course of treatment, after which the dose can be slightly reduced due to the relief of symptoms.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine for treating erythronoclastic anemia, and belongs to the technical field of medicines. The medicine is used for solving a treatment problem of erythronoclastic anemia, and mainly comprises the following traditional Chinese medicines in parts by mass: 15 parts of mulberry fruit, 15 parts of leech, 15 parts of prepared rehmannia root, 10 parts of seaweed, 15 parts of all-grass of madras grangea, 15 parts of codonopsis pilosula, 10 parts of Chinese date, 18 parts of twotooth achyranthes root, 15 parts of turtle shell, 15 parts of milkvetch root, 20 parts of Chinese yam and 7 parts of licorice root. The medicine for treating erythronoclastic anemia has the characteristics of a pharmaceutical composition with effects of nourishing blood, activating blood circulation, tonifying kidney, strengthening liver essence and nourishing blood, and achieves a significant and stable curative effect.

Description

technical field [0001] The invention relates to a medicine for treating hemolytic anemia, in particular to a medicine for treating hemolytic anemia, belonging to the technical field of medicine. Background technique [0002] Hemolytic anemia refers to a type of anemia that occurs when red blood cell destruction is accelerated and bone marrow hematopoietic function is insufficiently compensated. Anemia does not occur if the bone marrow is able to increase red blood cell production sufficiently to compensate for the shortened lifespan of red blood cells, a state called compensated hemolytic disease. "Hemolytic anemia", anemia caused by excessive destruction of red blood cells, but less common; often accompanied by jaundice, called "hemolytic jaundice". [0003] The etiology of hemolytic anemia: According to the reasons for the shortened lifespan of red blood cells, it can be divided into hemolytic anemia caused by intrinsic defects of red blood cells and external factors. 1....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8945A61P7/06A61K35/62A61K35/586
CPCA61K36/8945A61K9/0095A61K35/586A61K35/62A61K36/02A61K36/185A61K36/21A61K36/344A61K36/481A61K36/484A61K36/605A61K36/725A61K36/804
Inventor 黄全
Owner 黄全
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap